Cipher Pharmaceuticals Inc. (CPH:CA) Q1 2026 Earnings Call Transcript

Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Cipher Pharmaceuticals Quarterly Conference Call for the company’s Q1 2026 financial results. [Operator Instructions] As a reminder, this conference is being recorded today, Friday, May 8, 2026. On behalf of the speakers that follow, listeners are cautioned that today’s presentation and responses to questions may contain forward-looking statements within the meaning of the safe harbor provisions of the Canadian provincial securities laws. Forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on such statements.

Certain material factors or assumptions are implied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. For additional information about factors that could cause results to vary, please refer to the risks identified in the company’s annual information form and other filings with Canadian regulatory authorities, except as required by Canadian securities laws, the company does not undertake to update any forward-looking statements. Such statements speak only as of the date made. I would now like to turn the call over to Mr. Craig Mull, Interim Chief Executive Officer of the company. Please go ahead, Mr. Mull.

Craig Mull
Interim CEO & Chairman of the Board

Good morning, everyone, and thank you for joining us today. Before I begin, I’d like to remind everyone that all figures discussed on today’s call are expressed in U.S. dollars unless otherwise specified. Cipher’s first quarter of 2026 was an extension of our achievements during fiscal 2025. The U.S.-based Natroba business